Status:
ACTIVE_NOT_RECRUITING
A Prospective Longitudinal Study in Adults With Multifocal Motor Neuropathy
Lead Sponsor:
argenx
Conditions:
Multifocal Motor Neuropathy
Eligibility:
All Genders
18+ years
Brief Summary
This prospective longitudinal study will follow participants with Multifocal Motor Neuropathy over time and collect data on their clinical outcomes, quality of life, and use of health care resources. ...
Eligibility Criteria
Inclusion
- Is at least the local legal age of consent for clinical studies when signing the ICF
- Is capable of providing signed informed consent and complying with protocol requirements
- Has an existing or new diagnosis of MMN made by a neuromuscular specialist or neurologist
Exclusion
- Is currently participating in any clinical study with an IMP
- Has other medical conditions that could affect the assessment of MMN
Key Trial Info
Start Date :
November 29 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2026
Estimated Enrollment :
413 Patients enrolled
Trial Details
Trial ID
NCT05988073
Start Date
November 29 2023
End Date
December 31 2026
Last Update
June 20 2025
Active Locations (113)
Enter a location and click search to find clinical trials sorted by distance.
1
Neuromuscular Clinical and Research Center
Phoenix, Arizona, United States, 85028
2
HonorHealth Neurology - Bob Bove Neuroscience Institute
Scottsdale, Arizona, United States, 85251
3
UCI Health - ALS and Neuromuscular Center
Orange, California, United States, 92868
4
Stanford Medicine Health Care - Stanford Neuroscience Health Center
Palo Alto, California, United States, 94304